GS
Gilead Sciences Inc
🇩🇪XSTU.GISGermanyHealthcare
€126.12EURdown -0.16 (-0.13%)OpenEnd of day7:51 PM
Price€126.12-0.16 (-0.13%)
Profile
- Healthcare
- Drug Manufacturers - General
- Germany
Identity
- Exchange
- Stuttgart Stock Exchange . XSTU
- Type
- Stock
- ISIN
- US3755581036
- CUSIP
- Not reported
Company
- Employees
- 17,000
- Headquarters
- Foster City, United States
- Website
- https://www.gilead.com
- CEO
- Mr. Daniel Patrick O'Day
Market
- Shares outstanding
- 0
- Market cap
- Not reported
Key dates
- Next earnings
- Oct 29, 2026
Highlights
- Market cap
- Not reported
- EPS LTM
- -$2.61
- P/E LTM
- -48.47
- Div yield
- 2.59%
Fundamentals (LTM)
- Revenue
- $30.46B+5.52%up year on year
- Net income
- -$3.24B-151.34%down year on year
- Gross margin
- 79.59%+1.34%up year on year
- Free cash flow
- $13.2B+40.88%up year on year
Other listings
- XETR.GISXetra
- XMEX.GILDMexican Stock Exchange
- XFRA.GISFrankfurt Stock Exchange
- BVMF.GILD34B3 - Brasil Bolsa Balcão
- XNAS.GILDNasdaq
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.